| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.004 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.16 | 0.6 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.15 | 0.3 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.1 |